UK markets closed

Swedish Orphan Biovitrum AB (publ) (B6E.F)

Frankfurt - Frankfurt Delayed price. Currency in EUR
Add to watchlist
23.98+0.12 (+0.50%)
At close: 05:18PM CEST
Currency in EUR

Valuation measures4

Market cap (intra-day) 8.25B
Enterprise value 9.84B
Trailing P/E 44.13
Forward P/E 27.62
PEG ratio (5-yr expected) 1.36
Price/sales (ttm)4.02
Price/book (mrq)2.64
Enterprise value/revenue 0.43
Enterprise value/EBITDA 1.35

Trading information

Stock price history

Beta (5Y monthly) 0.25
52-week change 320.87%
S&P500 52-week change 325.59%
52-week high 326.46
52-week low 316.13
50-day moving average 323.28
200-day moving average 321.45

Share statistics

Avg vol (3-month) 35
Avg vol (10-day) 335
Shares outstanding 5339.87M
Implied shares outstanding 6345.58M
Float 8198.7M
% held by insiders 110.08%
% held by institutions 173.76%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Currency in SEK.

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Mar 2024

Profitability

Profit margin 9.26%
Operating margin (ttm)23.47%

Management effectiveness

Return on assets (ttm)4.51%
Return on equity (ttm)6.72%

Income statement

Revenue (ttm)23.14B
Revenue per share (ttm)69.38
Quarterly revenue growth (yoy)19.40%
Gross profit (ttm)N/A
EBITDA 7.77B
Net income avi to common (ttm)2.14B
Diluted EPS (ttm)0.54
Quarterly earnings growth (yoy)-25.00%

Balance sheet

Total cash (mrq)527M
Total cash per share (mrq)1.55
Total debt (mrq)19.22B
Total debt/equity (mrq)53.54%
Current ratio (mrq)0.71
Book value per share (mrq)3.55

Cash flow statement

Operating cash flow (ttm)4.74B
Levered free cash flow (ttm)2.69B